$30M sweet spot round size
Most of their 1 investments are in rounds between $30M and $30M
2008
Halozyme Therapeutics, Inc. raised $30M on February 6, 2019
Investors: argenx
$44M
from 19 investors over 19 rounds
argenx raised $33M on June 3, 2016
Investors: Burrage Capital Management, Aquila Capital, DAFNA Capital Management, LLC and MPM Capital
argenx raised $44M on December 1, 2011
Investors: Erasmus MC Biomedical Fund, LSP (Life Sciences Partners), Omnes, OrbiMed Advisors, Seventure Partners and Forbion
argenx raised $4.5M on February 11, 2010
Investors: BGV (BioGeneration Ventures), Thuja Capital, Omnes, EQT Life Sciences, Erasmus MC Biomedical Fund and Forbion
argenx raised $14M on September 10, 2009
Investors: Erasmus MC Biomedical Fund, BGV (BioGeneration Ventures) and Forbion